MA42964A - Préparation pharmaceutique anti-vieillissement - Google Patents

Préparation pharmaceutique anti-vieillissement

Info

Publication number: MA42964A
Authority: MA; Morocco
Prior art keywords: pharmaceutical preparation; aging pharmaceutical; aging; preparation; pharmaceutical
Prior art date: 2016-08-17

Application number

MA042964A

Other languages

English (en)

Inventor

Julio Reinecke

Peter Wehling

Original Assignee

Orthogen Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2016-08-17

Filing date

2017-05-12

Publication date

2018-08-01

2016-11-14 Priority claimed from PCT/EP2016/001888 external-priority patent/WO2017080669A1/fr

2017-05-12 Application filed by Orthogen Ag filed Critical Orthogen Ag

2018-08-01 Publication of MA42964A publication Critical patent/MA42964A/fr

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/16—Blood plasma; Blood serum
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A61K9/1277—Preparation processes; Proliposomes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/18—Antioxidants, e.g. antiradicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/10—Ophthalmic agents for accommodation disorders, e.g. myopia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Biomedical Technology (AREA)
Hematology (AREA)
Cell Biology (AREA)
Immunology (AREA)
Biotechnology (AREA)
Zoology (AREA)
Virology (AREA)
Developmental Biology & Embryology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Dermatology (AREA)
Biochemistry (AREA)
Toxicology (AREA)
Rheumatology (AREA)
Physical Education & Sports Medicine (AREA)
Ophthalmology & Optometry (AREA)
Orthopedic Medicine & Surgery (AREA)
Heart & Thoracic Surgery (AREA)
Diabetes (AREA)
Cardiology (AREA)
Pain & Pain Management (AREA)
Dispersion Chemistry (AREA)
Obesity (AREA)
Psychiatry (AREA)

MA042964A 2016-08-17 2017-05-12 Préparation pharmaceutique anti-vieillissement MA42964A (fr)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
EP16001807		2016-08-17
PCT/EP2016/001888 WO2017080669A1 (fr)	2015-11-13	2016-11-14	Préparation pharmaceutique efficace contre les troubles liés au vieillissement
PCT/EP2016/001887 WO2017080668A1 (fr)	2015-11-13	2016-11-14	Préparation pharmaceutique efficace contre les troubles liés au vieillissement

Publications (1)

Publication Number	Publication Date
MA42964A true MA42964A (fr)	2018-08-01

Family

ID=61196401

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
MA042963A MA42963A (fr)	2016-08-17	2017-05-11	Préparation pharmaceutique anti-vieillissement
MA042964A MA42964A (fr)	2016-08-17	2017-05-12	Préparation pharmaceutique anti-vieillissement

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
MA042963A MA42963A (fr)	2016-08-17	2017-05-11	Préparation pharmaceutique anti-vieillissement

Country Status (21)

Country	Link
US (3)	US20190290689A1 (fr)
EP (4)	EP3695845A1 (fr)
JP (2)	JP2019528281A (fr)
KR (2)	KR20190049690A (fr)
CN (2)	CN108348548A (fr)
AU (2)	AU2017313163B2 (fr)
BR (1)	BR112019002982A2 (fr)
CA (2)	CA3033045A1 (fr)
CL (2)	CL2019000420A1 (fr)
CO (2)	CO2019001232A2 (fr)
CR (2)	CR20190139A (fr)
EA (2)	EA201890841A1 (fr)
HK (3)	HK1258712A1 (fr)
IL (2)	IL259007B2 (fr)
MA (2)	MA42963A (fr)
MX (2)	MX2019001948A (fr)
PE (2)	PE20190627A1 (fr)
PH (2)	PH12019550017A1 (fr)
SG (2)	SG11201900866YA (fr)
TW (2)	TW201806606A (fr)
WO (3)	WO2018033226A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CR20190139A (es) *	2016-08-17	2019-06-03	Orthogen Ag	Preparación farmacéutica anti envejecimiento
CN108841784A (zh) *	2018-07-17	2018-11-20	温州医科大学附属第二医院、温州医科大学附属育英儿童医院	一种含黄芪甲苷的髓核细胞抗衰老抗凋亡培养基
EP3613424A1 (fr) *	2018-08-23	2020-02-26	Orthogen AG	Nouveaux procédés pour la production d'agents pharmaceutiques
RU2695264C1 (ru) *	2018-12-27	2019-07-22	федеральное государственное бюджетное образовательное учреждение высшего образования "Хакасский государственный университет им. Н.Ф. Катанова" (ФГБОУ ВО ХГУ им. Н.Ф. Катанова)	Способ прогнозирования ускоренного старения организма женщин, основанный на клинических данных о состоянии репродуктивной функции
KR20210109556A (ko) *	2018-12-27	2021-09-06	산토리 홀딩스 가부시키가이샤	변성 엘라스틴의 분해 저하의 억제제, 정상적인 엘라스틴 섬유의 유지제, 엘라스틴-엘라핀 복합체 형성 억제제 및 엘라스틴-엘라핀 복합체 형성 억제 작용을 갖는 물질의 스크리닝 방법
TWI787697B (zh)	2019-12-30	2022-12-21	財團法人工業技術研究院	外泌體的分離方法、膠體粒子及其製備方法
US12077780B2 (en)	2020-02-14	2024-09-03	Allergan Sales, Llc	Conditioned medium from cells cultured under hypoxic conditions and uses thereof
WO2023221980A1 (fr) *	2022-05-16	2023-11-23	台湾粒线体应用技术股份有限公司	Composition pour atténuer des lésions auditives et son utilisation
JP7624256B1 (ja) *	2024-01-26	2025-01-30	万里坂井	医薬組成物及びその製造方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR20070058441A (ko) *	2004-07-01	2007-06-08	유니버시티 오브 피츠버그 오브 더 커먼웰쓰 시스템 오브 하이어 에듀케이션	면역억제성 엑소솜
DE102006005016A1 (de) *	2006-02-03	2007-08-16	Orthogen Ag	Konditionierte Blutzusammensetzung und Verfahren zu deren Herstellung
DE202009017772U1 (de) *	2009-12-10	2011-04-21	Orthogen Ag	Kombinationspräparate mit Cytokin-Antagonist und Corticosteroid
WO2012076193A1 (fr) *	2010-12-10	2012-06-14	Orthogen Ag	Préparations combinées contenant des exosomes et un corticostéroïde
US9828603B2 (en) *	2012-08-13	2017-11-28	Cedars Sinai Medical Center	Exosomes and micro-ribonucleic acids for tissue regeneration
DE102012019088A1 (de) *	2012-09-28	2014-04-03	Orthogen Ag	Antibakterielle Arzneimittelpräparate
CN103767985A (zh) *	2012-10-22	2014-05-07	吉林省霍普金斯药物研究院有限责任公司	人源血液或间充质干细胞分泌exosome的制备与应用
KR101784050B1 (ko) *	2014-12-23	2017-10-10	영남대학교 산학협력단	엑소솜을 유효성분으로 함유하는 피부 노화 예방 또는 치료용 약학조성물
CN105477016A (zh) *	2015-11-13	2016-04-13	中国人民解放军第二军医大学	人间充质干细胞来源的外泌体在抗组织纤维化及瘢痕形成中的应用
WO2017080669A1 (fr) *	2015-11-13	2017-05-18	Orthogen Ag	Préparation pharmaceutique efficace contre les troubles liés au vieillissement
CN105505854B (zh) *	2016-01-14	2019-07-12	上海市第六人民医院	来源于人尿液细胞的外泌体的获取方法与应用
CN105582576B (zh) *	2016-02-23	2018-08-17	武汉大复生物科技有限公司	提高内皮祖细胞外泌体释放并促进骨缺损修复的生物材料、制备方法及用途
CR20190139A (es) *	2016-08-17	2019-06-03	Orthogen Ag	Preparación farmacéutica anti envejecimiento

2017
- 2017-05-11 CR CR20190139A patent/CR20190139A/es unknown
- 2017-05-11 EA EA201890841A patent/EA201890841A1/ru unknown
- 2017-05-11 SG SG11201900866YA patent/SG11201900866YA/en unknown
- 2017-05-11 MA MA042963A patent/MA42963A/fr unknown
- 2017-05-11 US US16/325,870 patent/US20190290689A1/en not_active Abandoned
- 2017-05-11 WO PCT/EP2017/000574 patent/WO2018033226A1/fr not_active Ceased
- 2017-05-11 AU AU2017313163A patent/AU2017313163B2/en active Active
- 2017-05-11 EP EP20155846.7A patent/EP3695845A1/fr active Pending
- 2017-05-11 KR KR1020197003441A patent/KR20190049690A/ko not_active Ceased
- 2017-05-11 MX MX2019001948A patent/MX2019001948A/es unknown
- 2017-05-11 EP EP17728051.8A patent/EP3352769A1/fr not_active Withdrawn
- 2017-05-11 CA CA3033045A patent/CA3033045A1/fr active Pending
- 2017-05-11 JP JP2019508969A patent/JP2019528281A/ja active Pending
- 2017-05-11 IL IL259007A patent/IL259007B2/en unknown
- 2017-05-11 HK HK19101113.9A patent/HK1258712A1/zh unknown
- 2017-05-11 CN CN201780003804.9A patent/CN108348548A/zh active Pending
- 2017-05-11 PE PE2019000304A patent/PE20190627A1/es not_active Application Discontinuation
- 2017-05-12 HK HK18114754.7A patent/HK1255619A1/zh unknown
- 2017-05-12 PE PE2019000361A patent/PE20190517A1/es not_active Application Discontinuation
- 2017-05-12 MX MX2019001949A patent/MX2019001949A/es unknown
- 2017-05-12 BR BR112019002982-6A patent/BR112019002982A2/pt not_active Application Discontinuation
- 2017-05-12 EP EP17728052.6A patent/EP3352770A1/fr not_active Withdrawn
- 2017-05-12 TW TW106115816A patent/TW201806606A/zh unknown
- 2017-05-12 CR CR20190091A patent/CR20190091A/es unknown
- 2017-05-12 EP EP20163717.0A patent/EP3763377A1/fr not_active Withdrawn
- 2017-05-12 MA MA042964A patent/MA42964A/fr unknown
- 2017-05-12 KR KR1020197004442A patent/KR20190046793A/ko not_active Withdrawn
- 2017-05-12 WO PCT/EP2017/000581 patent/WO2018033227A1/fr not_active Ceased
- 2017-05-12 TW TW106115815A patent/TW201806605A/zh unknown
- 2017-05-12 EA EA201890840A patent/EA201890840A1/ru unknown
- 2017-05-12 US US16/325,945 patent/US20210290671A1/en not_active Abandoned
- 2017-05-12 SG SG11201901085RA patent/SG11201901085RA/en unknown
- 2017-05-12 JP JP2019508931A patent/JP2019529357A/ja active Pending
- 2017-05-12 CA CA3033899A patent/CA3033899A1/fr not_active Abandoned
- 2017-05-12 AU AU2017313164A patent/AU2017313164B2/en active Active
- 2017-05-12 CN CN201780003805.3A patent/CN108348549A/zh active Pending
- 2017-05-12 HK HK19101111.1A patent/HK1259143A1/zh unknown
- 2017-08-17 US US16/325,944 patent/US20190231816A1/en not_active Abandoned
- 2017-08-17 WO PCT/EP2017/000994 patent/WO2018033249A1/fr not_active Ceased
2018
- 2018-04-29 IL IL259006A patent/IL259006A/en unknown
2019
- 2019-01-30 PH PH12019550017A patent/PH12019550017A1/en unknown
- 2019-02-08 PH PH12019550022A patent/PH12019550022A1/en unknown
- 2019-02-12 CO CONC2019/0001232A patent/CO2019001232A2/es unknown
- 2019-02-13 CO CONC2019/0001265A patent/CO2019001265A2/es unknown
- 2019-02-15 CL CL2019000420A patent/CL2019000420A1/es unknown
- 2019-02-15 CL CL2019000419A patent/CL2019000419A1/es unknown

Also Published As

Publication number	Publication date
IL259007B1 (en)	2024-03-01
WO2018033249A1 (fr)	2018-02-22
CR20190139A (es)	2019-06-03
KR20190049690A (ko)	2019-05-09
TW201806605A (zh)	2018-03-01
WO2018033227A1 (fr)	2018-02-22
MX2019001948A (es)	2019-05-15
HK1258712A1 (zh)	2019-11-15
SG11201901085RA (en)	2019-03-28
CO2019001232A2 (es)	2019-02-28
CL2019000420A1 (es)	2019-07-05
WO2018033226A1 (fr)	2018-02-22
IL259006A (en)	2018-07-31
CL2019000419A1 (es)	2019-07-05
EP3352769A1 (fr)	2018-08-01
JP2019529357A (ja)	2019-10-17
PE20190517A1 (es)	2019-04-10
MX2019001949A (es)	2019-05-15
BR112019002982A2 (pt)	2019-05-14
IL259007A (en)	2018-07-31
PH12019550017A1 (en)	2019-11-04
CN108348549A (zh)	2018-07-31
HK1255619A1 (zh)	2019-08-23
EA201890840A1 (ru)	2018-09-28
CA3033899A1 (fr)	2018-02-22
KR20190046793A (ko)	2019-05-07
US20190231816A1 (en)	2019-08-01
JP2019528281A (ja)	2019-10-10
US20190290689A1 (en)	2019-09-26
EP3352770A1 (fr)	2018-08-01
WO2018033227A8 (fr)	2019-01-24
HK1259143A1 (zh)	2019-11-29
PE20190627A1 (es)	2019-04-26
PH12019550022A1 (en)	2019-12-02
TW201806606A (zh)	2018-03-01
AU2017313163A1 (en)	2018-05-10
AU2017313164A1 (en)	2018-05-10
EP3695845A1 (fr)	2020-08-19
EP3763377A1 (fr)	2021-01-13
CA3033045A1 (fr)	2018-02-22
AU2017313164B2 (en)	2019-01-03
AU2017313163B2 (en)	2019-01-03
US20210290671A1 (en)	2021-09-23
CN108348548A (zh)	2018-07-31
CO2019001265A2 (es)	2019-02-28
CR20190091A (es)	2019-05-07
MA42963A (fr)	2018-08-01
SG11201900866YA (en)	2019-02-27
EA201890841A1 (ru)	2018-09-28
IL259007B2 (en)	2024-07-01
BR112019002080A2 (pt)	2019-05-14

Publication	Publication Date	Title
IL282304A (en)	2021-05-31	Topical pharmaceutical compositions
EP3493799A4 (fr)	2020-04-01	Composition pharmaceutique decannabis
EP3493798A4 (fr)	2020-05-06	Composition pharmaceutique decannabis
EP3454899C0 (fr)	2024-03-20	Composition pharmaceutique
IL253719A0 (en)	2017-09-28	Pharmaceutical compositions for combination therapy
HUE054344T2 (hu)	2021-08-30	Gyógyászati készítmények AZD9291 tartalommal
DK3529248T3 (da)	2020-09-14	Farmaceutiske sammensætninger
MA42964A (fr)	2018-08-01	Préparation pharmaceutique anti-vieillissement
SI4070787T1 (sl)	2023-07-31	Farmacevtske formulacije
EP3476386C0 (fr)	2024-01-24	Composition pharmaceutique liquide
MA43705A (fr)	2018-11-28	Formulation pharmaceutique
DK3199161T3 (da)	2022-01-03	Farmaceutisk præparat
DK3529240T3 (da)	2020-09-07	Farmaceutiske forbindelser
EP3603642A4 (fr)	2020-09-02	Préparation pharmaceutique
EP3452075A4 (fr)	2019-12-11	Composition pharmaceutique ophtalmique
DK3634377T3 (da)	2021-08-30	Farmaceutisk formulering
DK3463345T3 (da)	2023-01-09	Farmaceutiske kombinationer
MA47516A (fr)	2021-03-31	Composition pharmaceutique
EP3383371A4 (fr)	2019-07-24	Formulation pharmaceutique
EP3402470A4 (fr)	2019-11-13	Composition pharmaceutique stable
EP3646866A4 (fr)	2021-03-24	Préparation pharmaceutique
DK3280447T3 (da)	2019-05-13	Farmaceutiske formuleringer
EP3459369A4 (fr)	2019-12-11	Composition pharmaceutique utilisant la souchelactobacillus
DK3313370T3 (da)	2021-03-29	Oftalmologisk farmaceutisk sammensætning
EP3646867A4 (fr)	2021-03-24	Composition pharmaceutique